Status:
UNKNOWN
Application of Enhanced Recovery After Surgery for Congenital Esophageal Atresia During Perioperative Period
Lead Sponsor:
Guangzhou Women and Children's Medical Center
Conditions:
Esophageal Atresia
Enhanced Recovery After Surgery
Eligibility:
All Genders
1-1 years
Brief Summary
The purpose of this prospective cohort study is to evaluate the safety and effectiveness of enhanced recovery after surgery (ERAS) to perform routine thoracoscopic repair for elective esophageal atres...
Detailed Description
The concept of enhanced recovery after surgery was introduced by Kelhet et al. in the 1990s for colorectal surgery, and it referred to a group of measures performed during a patient's treatment course...
Eligibility Criteria
Inclusion
- congenital esophageal atresia with type C
- the distance of blind end is less than 2.5cm
- weight\>2.4Kg
- without related malformations (heart, kidney),
- without structural heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)
Exclusion
- Type A/B/D/E esophageal atresia
- the distance of blind end is more than 2.5cm
- weight is less than 2.4Kg
- with Inherited chromosomal related diseases
- with congenital heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)
- preoperative severe pneumonia need mechanical ventilation
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04072419
Start Date
September 1 2019
End Date
December 30 2022
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Women and Children's Medical Cente
Guangzhou, China